TRAVERE THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
TRAVERE THERAPEUTICS, INC. (TVTX) reported Earnings Per Share, Basic and Diluted of -$2.37 per share for the 3-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-03-01
- TRAVERE THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$2.37.
- TRAVERE THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.44.
- TRAVERE THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.58.
- TRAVERE THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was $0.02.
- TRAVERE THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$3.56.
- TRAVERE THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$3.46.
- TRAVERE THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$2.54.
- TRAVERE THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2017 was -$1.54.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 10 month | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | -$2.37 10-K · filed 2021-03-01 | -$3.56 10-K · filed 2021-03-01 | ||||||
| 2020-09-30 | -$0.44 10-K · filed 2021-03-01 | -$1.03 10-Q · filed 2020-11-05 | ||||||
| 2020-06-30 | -$0.58 10-K · filed 2021-03-01 | -$0.57 10-Q · filed 2020-07-31 | ||||||
| 2020-03-31 | $0.02 10-K · filed 2021-03-01 | |||||||
| 2019-12-31 | -$0.70 10-K · filed 2021-03-01 | -$3.46 10-K · filed 2021-03-01 | ||||||
| 2019-09-30 | -$0.85 10-K · filed 2021-03-01 | -$2.76 10-Q · filed 2020-11-05 | ||||||
| 2019-06-30 | -$0.92 10-K · filed 2021-03-01 | -$1.91 10-Q · filed 2020-07-31 | ||||||
| 2019-03-31 | -$0.99 10-K · filed 2021-03-01 | |||||||
| 2018-12-31 | -$0.18 10-K · filed 2020-02-24 | -$2.54 10-K · filed 2021-03-01 | ||||||
| 2018-09-30 | -$1.34 10-K · filed 2020-02-24 | -$2.37 10-Q · filed 2019-10-30 | ||||||
| 2018-06-30 | -$0.56 10-K · filed 2020-02-24 | -$1.03 10-Q · filed 2019-08-06 | ||||||
| 2018-03-31 | -$0.46 10-K · filed 2020-02-24 | |||||||
| 2017-12-31 | -$1.54 10-K · filed 2020-02-24 | |||||||
| 2017-09-30 | -$0.46 10-Q · filed 2018-11-01 | -$1.10 10-Q · filed 2018-11-01 | ||||||
| 2017-06-30 | -$0.34 10-Q · filed 2018-08-03 | -$0.63 10-Q · filed 2018-08-03 | ||||||
| 2014-12-31 | -$4.43 10-K · filed 2015-03-11 | |||||||
| 2014-03-31 | -$3.03 10-Q · filed 2014-05-15 | |||||||
| 2013-12-31 | -$0.70 10-K · filed 2015-03-11 | -$2.44 10-K/A · filed 2015-07-09 | -$2.38 10-K · filed 2014-03-28 | |||||
| 2013-09-30 | -$0.78 10-Q/A · filed 2015-07-09 | -$0.71 10-Q · filed 2013-11-13 | -$1.72 10-Q/A · filed 2015-07-09 | -$1.62 10-Q · filed 2013-11-13 | ||||
| 2013-06-30 | -$0.40 10-K · filed 2015-03-11 | -$0.41 10-Q · filed 2013-09-16 | -$0.85 10-Q · filed 2013-09-16 | |||||
| 2013-03-31 | -$0.46 10-K · filed 2015-03-11 | -$0.44 10-Q · filed 2013-07-24 | ||||||
| 2012-12-31 | -$8.29 10-K/A · filed 2015-07-09 | |||||||
| 2012-11-30 | -$0.03 10-Q · filed 2013-03-06 | -$0.10 10-Q · filed 2013-03-06 | ||||||
| 2012-09-30 | -$2.42 10-Q/A · filed 2015-07-09 | -$5.55 10-Q/A · filed 2015-07-09 | ||||||
| 2012-06-30 | -$1.55 10-Q · filed 2013-09-16 | -$3.00 10-Q · filed 2013-09-16 | ||||||
| 2012-03-31 | -$1.43 10-Q/A · filed 2013-09-16 | |||||||
| 2011-12-31 | -$1.59 10-K/A · filed 2013-09-16 | |||||||
| 2011-11-30 | -$0.03 10-Q · filed 2013-03-06 | -$0.10 10-Q · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |